Monday, November, 23 at 12pm EDT

Amidst the coronavirus pandemic, adoption of digital tools has accelerated with use cases expanding across the health care industry (including health systems, payers and biopharma and devices companies). FDA approvals for digital therapeutics and the $38 billion Teladoc-Livongo merger represent significant milestones in the maturation of the digital health sector. This webinar will examine emerging business models and the state of digital health in a very dynamic clinical, reimbursement and regulatory environment.

Register for Webinar

  • Register Here